Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.64 USD -2.94%
Market Cap: 777.9m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcellera Biologics Inc
Research & Development Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Research & Development
-$175.7m
CAGR 3-Years
-81%
CAGR 5-Years
-98%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Research & Development
-CA$5.2m
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
-54%
Replicel Life Sciences Inc
XTSX:RP
Research & Development
-CA$514.3k
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
7%
Innovotech Inc
XTSX:IOT
Research & Development
-CA$235.6k
CAGR 3-Years
-92%
CAGR 5-Years
-49%
CAGR 10-Years
7%

See Also

What is Abcellera Biologics Inc's Research & Development?
Research & Development
-175.7m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Research & Development amounts to -175.7m USD.

What is Abcellera Biologics Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-98%

Over the last year, the Research & Development growth was -63%. The average annual Research & Development growth rates for Abcellera Biologics Inc have been -81% over the past three years , -98% over the past five years .

Back to Top